- Home
- FBIO vs RFL Comparison
FBIO vs RFL Comparison
Compare FBIO & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- RFL
- Stock Information
- Founded
- FBIO 2006
- RFL 2017
- Country
- FBIO United States
- RFL United States
- Employees
- FBIO N/A
- RFL N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- RFL Real Estate
- Sector
- FBIO Health Care
- RFL Finance
- Exchange
- FBIO Nasdaq
- RFL Nasdaq
- Market Cap
- FBIO 49.1M
- RFL 48.4M
- IPO Year
- FBIO N/A
- RFL N/A
- Fundamental
- Price
- FBIO $1.80
- RFL $1.58
- Analyst Decision
- FBIO Strong Buy
- RFL
- Analyst Count
- FBIO 2
- RFL 0
- Target Price
- FBIO $21.00
- RFL N/A
- AVG Volume (30 Days)
- FBIO 229.4K
- RFL 443.3K
- Earning Date
- FBIO 08-12-2025
- RFL 06-11-2025
- Dividend Yield
- FBIO N/A
- RFL N/A
- EPS Growth
- FBIO N/A
- RFL N/A
- EPS
- FBIO N/A
- RFL N/A
- Revenue
- FBIO $57,784,000.00
- RFL $732,000.00
- Revenue This Year
- FBIO $51.59
- RFL N/A
- Revenue Next Year
- FBIO $44.74
- RFL N/A
- P/E Ratio
- FBIO N/A
- RFL N/A
- Revenue Growth
- FBIO N/A
- RFL 35.56
- 52 Week Low
- FBIO $1.33
- RFL $1.27
- 52 Week High
- FBIO $2.89
- RFL $3.19
- Technical
- Relative Strength Index (RSI)
- FBIO 49.69
- RFL 45.94
- Support Level
- FBIO $1.78
- RFL $1.41
- Resistance Level
- FBIO $2.15
- RFL $3.19
- Average True Range (ATR)
- FBIO 0.10
- RFL 0.29
- MACD
- FBIO -0.02
- RFL -0.03
- Stochastic Oscillator
- FBIO 18.92
- RFL 9.47
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.